SIRT1 and Other metabolic disease: Moreover, activation of SIRT1 is protective against metabolic disorders known to affect patients with SBMA, such as nonalcoholic fatty liver disease (12, 75, 76), impaired glucose homeostasis (12, 13, 15, 36, 70), and mitochondrial dysfunction (35, 52, 65).